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Abstract
Background: Scaffold attachment factor A (SAF-A) participates in the regulation of gene expression by organizing
chromatin into transcriptionally active domains and by interacting directly with RNA polymerase II.
Methodology: Here we use co-localization, co-immunoprecipitation (co-IP) and in situ proximity ligation assay (PLA) to
identify Brahma Related Gene 1 (BRG1), the ATP-driven motor of the human SWI-SNF chromatin remodeling complex, as
another SAF-A interaction partner in mouse embryonic stem (mES) cells. We also employ RNA interference to investigate
functional aspects of the SAF-A/BRG1 interaction.
Principal Findings: We find that endogenous SAF-A protein interacts with endogenous BRG1 protein in mES cells, and that
the interaction does not solely depend on the presence of mRNA. Moreover the interaction remains intact when cells are
induced to differentiate. Functional analyses reveal that dual depletion of SAF-A and BRG1 abolishes global transcription by
RNA polymerase II, while the nucleolar RNA polymerase I transcription machinery remains unaffected.
Conclusions: We demonstrate that SAF-A interacts with BRG1 and that both components are required for RNA Polymerase II
Mediated Transcription.
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Introduction
Transcription of nuclear genes is mediated by RNA polymerase
II (Pol II) and proceeds through three main phases referred to as
transcription initiation, transcription elongation and transcription
termination [1]. Each of these phases is regulated in a variety of
more or less gene specific ways to produce appropriate amounts of
mRNA. Eukaryotic gene transcription is further controlled by
reversible covalent histone modifications like methylation, phos-
phorylation or acetylation, which serve to alter local chromatin
structure, and by ATP-dependent chromatin remodeling which
serves to actively disrupt histone-DNA interactions [2].
SAF-A, also known as heterogeneous nuclear ribonucleoprotein
U (hnRNP U), is an abundant nuclear protein that binds single-
and double-stranded DNA [3,4] and RNA [5], and organizes
chromatin into functional gene domains [6]. It is important during
early embryonic development and previous reports have indicated
that SAF-A is involved in transcriptional regulation of specific
genes due to its association with elements within the promoter
regions of apo-D, bmal1 and developmentally regulated genes shh,
klf2 and oct4 [7,8,9,10,11] as well as with transcription factors such
as the glucocorticoid hormone receptor, WT1, BRN4, SOX2 and
OCT4 [10,12,13,14]. SAF-A has also been demonstrated to
interact directly with Pol II in HeLa cells [15,16] and mES cells
[10]. Thus SAF-A has been implicated in a variety of events
related to transcriptional regulation of gene expression. In addition
SAF-A has been reported to interact with epigenetic controllers of
gene expression like CREB-binding protein (CBP) and P300/CBP
associated factor (PCAF) [17,18], and more recently SAF-A was
shown to also interact with DNA methyltransferase DNMT1 [19].
In mammals the ATPase enzymatic activity of Brahma (BRM)
and BRG1, also known as SWI/SNF related matrix associated
actin dependent regulator of chromatin 4 (SMARCA4), provides
the energy needed to remodel chromatin. The BRG1 protein
preferentially associates with acetylated histones [20,21,22,23] and
was recently reported to help Pol II overcome nucleosomal
barriers during transcription elongation in vivo [24]. The brg1 gene
is expressed in ES cells [25], and the encoded BRG1 protein
associates with the nuclear matrix [26], is involved in chromatin
loop formation [27], interacts with Pol II [28], regulates expression
of pluripotency genes [29], and has been reported to be important
for embryonic development [30,31]. In the same way the saf-A
gene is expressed in ES cells [10], and the encoded SAF-A protein
associates with the nuclear envelope [6], is involved in chromatin
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28049loop formation [6], interacts with Pol II [10,15,16], and has been
reported to be important for embryonic development [11,32].
These similarities prompted us to explore the possibility that SAF-
A and BRG1 in some way co-operate to regulate gene expression
in ES cells, and if so, to investigate functional aspects of a possible
SAF-A/BRG1 interaction.
Results
SAF-A interacts with BRG1 in mES cells
The spatial distributions of endogenous SAF-A and endog-
enous BRG1 were first examined in mES cells by immunoflu-
orescence followed by confocal microscopy with sequential
scanning of two channels, each corresponding to one protein. As
expected, both SAF-A and BRG1 were found to localize to the
nucleus of mES cells. The ImageJ software (http://rsb.info.nih.
gov/ij), which was used to visualize the spatial distributions of
endogenous SAF-A (Figure 1A, green) and endogenous BRG1
(Figure 1A, red) in interphase ES cells, reveals practically
complete co-localization of SAF-A and BRG1 (Figure 1A,
white).
The co-localization results encouraged us to perform co-
immunoprecipitation (co-IP) experiments. Total extracts prepared
from mES cells were subjected to co-IP with anti-SAF-A. SAF-A-
immunoprecipitated proteins were fractionated by SDS- PAGE
and analyzed by Western blotting using anti-SAF-A and anti-
BRG1. Endogenous BRG1 was co-immunoprecipitated by anti-
SAF-A whereas none of the analyzed proteins were co-precipitated
by normal rabbit IgG (Figure 1B).
To confirm co-localization and co-IP results, and to visualize
endogenous protein-protein interactions in single cells, we next
employed in situ proximity ligation assay (PLA) [33]. Technical
and biological controls (Figure S1) show that the PLA method-
ology is highly specific, and by using in situ PLA followed by
confocal microscopy, a large number of endogenous SAF-A/
BRG1 interactions can be visualized in nuclei of pluripotent mES
cells (Figure 1C). This confirms the co-localization and co-IP
results, and suggests that endogenous SAF-A interacts with
endogenous BRG1 in mES cells.
The SAF-A/BRG1 interaction does not solely depend on
the presence of mRNA
Because hnRNP proteins such as SAF-A are involved in
splicing [5], and the BRG1 homologue BRM has been
implicated in splicing [34], we decided to investigate whether
the SAF-A/BRG1 interaction depends on the presence of RNA.
To this end total extracts prepared from mES cells were treated
with RNase A followed by co-IP with anti-SAF-A. SAF-A-
immunoprecipitated proteins were fractionated by SDS-PAGE
and analyzed by Western blotting using anti-SAF-A and anti-
BRG1 as above. This revealed that the SAF-A/BRG1
interaction does not solely depend on the presence of mRNA
(Figure 2A). Similarly, using in situ PLA a large number of
endogenous SAF-A/BRG1 interactions can be visualized in
RNase A treated nuclei of pluripotent mES cells (Figure 2B).
Thus given the comparably small size of RNase A (13.7 kDa) the
SAF-A/BRG1 interaction demonstrated by Co-IP and PLA does
not merely reflect that SAF-A and BRG1 are found in close
proximity due to being simultaneously bound to the same
mRNA molecule independently of each other.
In summary, RNase A treatment in combination with Co-IP
and in situ PLA suggests that the SAF-A/BRG1 interaction does
not solely depend on the presence of mRNA.
The SAF-A/BRG1 interaction is unaffected by cellular
differentiation
To investigate if the observed SAF-A/BRG1 interaction is
maintained during differentiation of mES cells, in situ PLA was
performed and analyzed by confocal microscopy. Induction of
mES cell differentiation was achieved by either withdrawal of
leukemia inhibitory factor (LIF) (Figure S2, left panel), which is
essential for pluripotency and self-renewal of mES cells [35,36],
or by the addition of RA to the culture medium (Figure S2, right
panel). Cellular differentiation induced by either LIF withdraw-
al for two days (Figure 3, 2LIF) or by the addition of RA
(Figure 3, +RA) to the culture medium does not significantly
affect the amount of endogenous SAF-A/BRG1 interactions in
comparison to control experiments (Figure 3, +LIF). These
findings suggest that the observed interaction between endog-
enous SAF-A and endogenous BRG1 is unaffected by cellular
differentiation.
SAF-A needs to interact with BRG1 for RNA polymerase II
mediated transcription
We continued by exploring functional effects of SAF-A and
BRG1. Knockdown of the saf-A and brg1 genes on their own, as
well as both genes together, was achieved by short hairpin (sh)
RNA. In preliminary experiments four saf-A- and brg1-targeting
constructs containing antibiotic selection were tested for their
ability to knock down mRNA at three different concentrations
48 h post transfection. Similar effects were observed for all four
independent saf-A and brg1 targeting sequences. The two saf- A-
shRNA and the two brg1-shRNA constructs that resulted in slightly
more efficient knockdowns were used in subsequent experiments.
At 48 h post transfection, saf-A and brg1 transcript levels were
lower in saf-A, brg1 and in doubly saf-A/brg1 depleted cells
(Figure 4A). Albeit at 96 h post transfection, saf-A and brg1
deficiency also yielded lower levels of total RNA (data not shown)
as well as housekeeping gene mRNA. Western blotting confirms
that shRNA generates a concentration dependent decrease of
SAF-A protein 48 hours post transfection (Figure S3), even though
SAF-A is known to be a very stable protein.
This discovery encouraged us to investigate whether deficiency
of SAF-A, BRG1, or both proteins jointly, affects global
transcription in mES cells. Global transcription was measured in
live control, saf-A, brg1 and saf-A/brg1 knockdown mES cells by
incorporation of 5-ethynyl uridine (EU) into nascent RNA
transcripts under experimental conditions that reveal specific
transcription by Pol II. Endogenous protein levels and EU
incorporation was analysed by immunofluorescence confocal
microscopy at two different time points post transfection. At
48 h post transfection, the knockdown cells were positive for EU
incorporation although visible levels of the endogenous proteins
were undetectable. However, quantification of saf-A and brg1
knockdown effects on global transcription revealed that the
proportion of transcriptionally active (EU positive) cells when
SAF-A and BRG1 were depleted decreased by 1% and 26% in
comparison to the negative control-shRNA, respectively. The dual
SAF-A and BRG1 depletion resulted in a decrease of EU positive
cells by 42% (Figure 4B). At 72 hours post transfection,
endogenous SAF-A and BRG1 were undetectable (Figure 4C).
The proportion of transcriptionally active (EU positive) cells when
SAF-A and BRG1 were depleted decreased by 57% and 54%,
respectively, in comparison to the negative control-shRNA. More
notably, simultaneous depletion of SAF-A and BRG1 resulted in a
dramatic 92% decrease of EU positive cells in comparison to the
negative control-shRNA (Figure 4B, C). Albeit incorporation of
A SAF-A/BRG1 Complex
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that RNA polymerase I mediated transcription is unaffected by
depletion of SAF-A and BRG1, and points toward a specific and
fundamental role for the SAF-A/BRG1 interaction in global Pol II
mediated transcription.
Discussion
In summary, we demonstrate by two independent techniques,
co-IP and in situ PLA, that SAF-A, a constituent of the nuclear
matrix, interacts with BRG1, the ATP-driven motor of the human
Figure 1. SAF-A and BRG1 interact in ES cells. (A) Immunoflurescent confocal microscopy shows that SAF-A (green) and BRG1 (red) localize to
cell nuclei, and also reveals an almost complete co-localization between SAF-A and BRG1 (white). DNA was counterstained with DAPI (blue). Scale
bars represent 10 mm. (B) Total ES cell extract was subjected to co-immunoprecipitation by anti-SAF-A and normal IgG as negative control. SAF-A-
bound proteins were eluted, fractionated by SDS-PAGE and analyzed by Western blotting by anti-SAF-A and anti-BRG1. (C) Immunofluorescent
confocal microscopy in combination with in situ proximity ligation assay was used to detect and visualize SAF-A/BRG1 interactions in ES cells.
Irrespective of intensity each red dot represents a single endogenous SAF-A protein in close proximity to a single endogenous BRG1 protein. Confocal
micrographs were collected at 0.38 mm intervals to create Z axis stacks, which were merged to render images of SAF-A/BRG1 interactions. DNA was
counterstained with DAPI (blue). Scale bars represent 10 mm.
doi:10.1371/journal.pone.0028049.g001
A SAF-A/BRG1 Complex
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the interaction does not solely depend on the presence of mRNA.
We also show that the SAF-A/BRG1 interaction persists when
mES cells are induced to differentiate. In addition, shRNA
mediated saf-A and brg1 knockdowns in combination with EU
incorporation analysis reveal that the SAF-A/BRG1 interaction is
required for global Pol II mediated transcription, and also
indicates that the proteins have complementary roles. Previous
reports have demonstrated that both saf-A and brg1 are expressed
in ES cells [10,25], and also that both encoded proteins associate
with the nuclear matrix [6,26], are involved in chromatin loop
formation [6,27], interact with Pol II [10,15,16,28], regulate
expression of pluripotency genes [10,29] and are important for
embryonic development [11,30,31,32].
Moreover, both SAF-A and BRG1 have been reported to
interact with actin [16,37] and DNA topoisomerase IIb [38,39]. In
combination with these reports, and the observation that
transcription is preferentially regulated at the nuclear periphery
in embryonic stem cells [40], our discoveries allow us to speculate
about possible roles for a SAF-A/BRG1 complex in gene
Figure 2. The SAF-A/BRG1 interaction does not solely depend on the presence of mRNA. (A) Untreated total ES cell extract, and total ES
cell extract treated with RNase A, were subjected to co-immunoprecipitation by anti-SAF-A and normal IgG as negative control. SAF-A-bound
proteins were eluted, fractionated by SDS-PAGE and analyzed by Western blotting by anti-SAF-A and anti-BRG1. (B) Immunofluorescent confocal
microscopy in combination with in situ proximity ligation assay was used to detect and visualize endogeneous SAF-A/BRG1 interactions in untreated
ES cells (-RNase A) and in ES cells treated with RNase A (+RNase A). Irrespective of intensity each red dot represents a single endogenous SAF-A
protein in close proximity to a single endogenous BRG1 protein. Confocal micrographs were collected at 0.38 mm intervals to create Z axis stacks,
which were merged to render images of SAF- A/BRG1 interactions. DNA was counterstained with DAPI (blue). Scale bars represent 10 mm.
doi:10.1371/journal.pone.0028049.g002
A SAF-A/BRG1 Complex
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gene locus by transporting the relevant chromatin domain along
the nuclear matrix until it reaches a transcription machinery,
perhaps located in the vicinity of a nuclear pore. Second, when the
relevant gene locus reaches the transcription machinery a SAF-A/
BRG1 complex may help the formation of a chromatin loop, in
which DNA topoisomerase IIb helps Pol II overcome topological
constraints during transcription.
Finally, SAF-A has been shown to decrease the rate of Pol II
mediated transcription [15] and BRG1 has been demonstrated
to increase the rate of Pol II mediated transcription [27], so
once transcription has begun SAF-A and BRG1 may provide a
brake and throttle, respectively, for Pol II during elongation.
The activation of a specific gene locus obviously depends on a
large number of additional factors, but it is worth noting that
S A F - A ,B R G 1 ,P o lI I ,D N At o p o i s o m e r a s eI I b and actin all are
present in all cell types so far investigated by the human protein
atlas project (www.proteinatlas.org). In conclusion, and regard-
less of exactly how a gene locus becomes transcriptionally ac-
tive, the data presented here suggests that a SAF-A/BRG1
interaction is required for RNA polymerase II mediated
transcription.
Materials and Methods
Cell cultures
Cell lines were grown at +37uC in humidified atmosphere
containing 5% CO2. Murine ES cell line R1 [41] (derived from
129X16129S1) was maintained on mitotically inactivated mouse
embryonic fibroblast (MEF) feeder layers in Dulbecco’s modified
Eagle medium supplemented with 1 mM sodium pyruvate,
0.1 mM non-essential amino acids, 2.0 mM L-glutamine,
0.1 mM beta-mercaptoethanol, 15% foetal bovine serum,
20 mM HEPES (pH 7.3), 100 U/100 mg penicillin/streptomycin
and 1000 U/ml LIF (ESGRO, Chemicon). Early differentiation of
mES cells was established by either leukemia inhibitory factor
(LIF) withdrawal or by the addition of retinoic acid (RA) from/to
the culture medium for 1–4 days.
Figure 3. The SAF-A/BRG1 interaction is unaffected by cell differentiation. Immunofluorescent confocal microscopy in combination with in
situ proximity ligation assay was used to detect and visualize endogeneous SAF-A/BRG1 interactions in ES cells and cells that were induced to
differentiate by withdrawal of leukaemia inhibitory factor (2LIF) or by the addition of Retinoic Acid (+RA). Irrespective of intensity each red dot
represents a single endogenous SAF-A protein in close proximity to a single endogenous BRG1 protein. Confocal micrographs were collected at
0.38 mm intervals to create Z axis stacks, which were merged to render images of SAF-A/BRG1 interactions. DNA was counterstained with DAPI (blue).
Scale bars represent 10 mm.
doi:10.1371/journal.pone.0028049.g003
A SAF-A/BRG1 Complex
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either control-shRNA or saf-A- and brg1-shRNA. Reverse transcriptase real time PCR analysis of control-, saf-A- and brg1-shRNA transfected ES cells
under puromycin selection was performed 48 h post transfection. Expression levels are normalized to gapdh. Data are mean6SD (n=3). (B) Global
transcription was detected in control and knockdown mES cells by incorporation of 5-ethynyl uridine (EU) 48 h and 72 h post transfection.
Percentage of EU positive knockdown cells in comparison to control cells 48 h (black bars) and 72 h (grey bars) post transfection. (C) EU incorporation
(green) and endogenous SAF-A (red) or BRG1 (red) protein levels were analyzed by immonofluorescence confocal microscopy in control and
knockdown mES cells 72 h post transfection. DNA was counterstained with DAPI (blue). Scale bars represent 10 mm.
doi:10.1371/journal.pone.0028049.g004
A SAF-A/BRG1 Complex
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Lysates were prepared from mES cells grown to 80–90%
confluence. Cells were washed three times with PBS and 5 mM
DTBP was added to stabilize protein-protein interactions prior to
lysis in 50 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 1% Triton X-
100, 5 mM EDTA, 1 mM phenylmethyl sulphonyl fluoride,
10 mg/ml aprotinin, 1 mg/ml leupeptin and pepstatin A. Lysed
cells were centrifuged for 10 min at 13,0006g. RNase A (Roche)
was added to a final concentration of 0.1 mg/ml and incubated for
30 min where indicated. The supernatant was pre-cleared and
incubated with antibodies and Protein A/G PLUS-Agarose beads
(Santa Cruz) overnight at +4uC. Anti-SAF-A and anti-BRG1
conjugated beads were centrifuged at 1,0006g and the superna-
tant was discarded. The beads were washed three times with 1 ml
of cold lysis buffer, resuspended in 20 ml2 6Laemli buffer, heated
to +95uC for 3 min and centrifuged for 1 min at 1,0006g.
Supernatants were collected and used for Western blot analysis.
Western blotting
Proteins were separated using SDS-PAGE, electrotransferred
onto polyvinylidene difluoride (PVDF) membranes for 1 h,
110 mA/gel in transfer buffer (48 mM Tris, 39 mM Glycin,
1.3 mM SDS, 10% MeOH) and immunologically detected. PVDF
membranes were blocked with 5% non-fat dry milk/0.1% Tween
20/PBS (PBST) and incubated overnight with primary antibodies
(anti-SAF-A (1:1000; ab20666; Abcam), anti-BRG1 (1:1000; sc-
17796; Santa Cruz)) diluted in blocking solution. After washing
with PBST, blots were incubated for 1 h with secondary
antibodies (AP conjugated goat anti-mouse IgM+IgG+IgA (H+L)
and AP conjugated goat anti-rabbit IgM+IgG (H+L chain specific)
(1:1000, SouthernBiotech)). Proteins were visualized with NBT/
BCIP (Promega).
Immunostaining
For imunofluorescence, cells were trypsinized, counted and
4.0610
4 cells were re- plated onto glass cover slips in 24-well
dishes and cultured overnight. Cells were fixed with 4.0%
paraformaldehyde/PBS for 20 min, washed, permeabilized with
0.25% Triton X-100/PBS for 5 min, blocked in 0.1% Triton X-
100/10% FCS/PBS for 20 min. Primary anti-SAF-A (1:500,
Abcam) and anti-BRG1 (Santa Cruz; sc-17796; 1:200) and
secondary antibodies (Alexa Fluor 488 conjugated goat anti-rabbit
IgG and Alexa Fluor 555 conjugated goat anti-mouse IgG (1:500,
Invitrogen)) were diluted in 0.1% Triton X-100/1% FCS/PBS
and added for 2 and 1 h respectively, each followed by washes in
0.1% Triton X-100/PBS. Nuclei were counterstained with DAPI.
Cover slips were air dried, mounted and analyzed on an inverted
Zeiss LSM 510 META confocal microscope equipped with a Zeiss
image processing system, using an 636/1.4 oil objective and
sequential scanning with the appropriate filter.
In situ proximity ligation assay
3–4610
4 cells were grown on eight-well chamber slides
overnight. Duolink (Olink Bioscience) in situ PLA was performed
according to the manufacturer’s protocol. Fixation, permeabiliza-
tion, blockage and primary antibody incubations were performed
as described for immunostaining analyzes. PLA probes were
diluted in 0.1% Triton X-100/1% FCS/PBS and incubated in
preheated humidity chamber for 1 h at +37uC, followed by
hybridization, ligation, amplification and detection according to
the manufacturer’s protocol. Slides were analyzed on an inverted
Zeiss LSM 510 META confocal microscope equipped with a Zeiss
image processing system, using a 636/1.4 oil objective and
sequential scanning with the appropriate filter.
ShRNAs and transfection
Four SureSilencing
TM shRNA plasmids with saf-A (saf-A-1: ACA
GTG TCT TGG CAA GTT TAT; saf-A-2: ACA GTG GTT TGT CTT
GAT ACT; saf-A-3: AGG CCG TGG AGG ATT CAA TAT; saf-A-4:
GAA CTC TCT TAT GCG AAG AAT) and brg1 (brg1-1: CTC GAG
GGT TCC CTG ATC TAT; brg1-2: TGA ACC TGG CTC TGA GTA
TTT; brg1-3: GAC CAC CTA TGA ATA TAT CAT; brg1-4: GCC AAG
GAC TTC AGG GAG TAT) specific insert sequences were obtained
from SABiosciences. Preparation of shRNA was done as
recommended by the manufacturer. 5610
4 ES cells were
transfected 4 h post seeding with 0.4, 0.8 and 1.0 mg shRNA
complexed with Lipofectamine
TM LTX Reagent (Invitrogen)
according to the manufacturer’s instructions. For each concentra-
tion of shRNA, an equivalent concentration of negative control-
shRNA was used. Transfected cells were selected by addition of
puromycin to a final concentration of 1 mg/ml (Calbiochem) 24 h
post transfection. 48 and 96 h post transfection cDNA levels of saf-
A, brg1 and gapdh were detected by real time PCR. Global
transcription status of the ES cells was analyzed 48 and 72 h post
transfection using immunofluorescence confocal microscopy.
RNA preparation/reverse transcription/real time PCR
analysis
Total RNA was extracted using RNeasy minikit (Qiagen).
Contaminating genomic DNA was eliminated with RNase-Free
DNase (Qiagen). cDNA synthesis was performed with Super-
Script III kit (Invitrogen). Endogenous mRNA levels were
measured by RT-qPCR analysis based on SYBR Green
detection. Briefly, the RT-qPCR mixture contained 1 ml of the
reverse transcription reaction product in a total volume of 20 ml,
containing 16SYBR Green mix reagent (Applied Biosystems),
50 nM forward primer and 50 nM reverse primer. Each sample
was analyzed in duplicate using the following oligonucleotide
pairs: saf-A Fwd (GCC GAG GGT ATT TTG AGT ACA T) and saf-A Rev
(TGT GTC ATC GAA GTG TTC GTC TT); gadph Fwd (AAT GTG TCC GTC
GTG GAT CTG A) and gadph Rev (GAT GCC TGC TTC ACC ACC TTC T).
All primer pairs yielded a single product as confirmed by
dissociation curve analyses, and gave no product in the no-
template control.
Global transcription assay
Global transcription was examined using Click-iTH RNA
Imaging Kit (Invitrogen). 5- ethynyl uridine (EU) was added at a
final concentration of 1 mM and incubated under normal cell
culture conditions for 1 h followed by fixation in 4%
paraformaldehyde/PBS for 20 min and permeabilized with
0.25% Triton X-100/PBS for 10 min. EU incorporation was
detected according to the manufacturer’s protocol with the
optional antibody detection step included. Primary anti-SAF-A
(1:500, Abcam), anti-BRG1 (1:200, Santa Cruz) and secondary
antibody (Alexa Fluor 555 conjugated goat anti-mouse IgG
(1:500, Invitrogen)) were diluted in 0.1% Triton X-100/1%
FCS/PBS and added for 2 and 1 h respectively, each followed
by washes in 0.1% Triton X-100/PBS. Nuclei were counter-
stained with 4,6-diamidino-2-phenylidole (DAPI). Fixated cells
were analyzed on an inverted Zeiss LSM 510 META confocal
microscope equipped with a Zeiss image processing system,
using an 636/1.4 oil objective and sequential scanning with
appropriate filters.
A SAF-A/BRG1 Complex
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Figure S1 In situ PLA is highly specific. The omission of
one or both primary antibodies yields no detectable signal
(negative technical controls). As a positive biological control the
previously reported interaction between SAF-A and Pol II is
clearly visualized by in situ PLA. DNA was counterstained with
Hoechst 33342 (blue). Scale bars represent 10 mm.
(TIF)
Figure S2 Transcript levels of saf-A and brg1 correlate
during the differentiation of murine embryonic stem
cells. Transcript levels of saf-A, brg1 and oct4 were determined in
undifferentiated and mES cells that were induced to differentiate
either by withdrawal of leukemia inhibitory factor (-LIF, left panel)
or by the addition of retinoic acid (+RA, right panel). Samples
were collected at twenty-four hour intervals for four days following
LIF withdrawal or RA treatment, respectively. Samples were
analyzed by real time PCR, and transcript levels were normalized
to gapdh mRNA levels. Data are mean6SD (n=3).
(TIF)
Figure S3 Western blotting confirms that shRNA gen-
erates a concentration dependent decrease of SAF-A
protein level 48 hours post transfection.
(TIF)
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